Thursday, 31 October 2019

Oligonucleotides Synthesis Market Set to Grow with CAGR of 9.3% By 2026 With Leading Players Agilent Technologies, Inc., Atdbio Ltd., LGC Limited, Bio-Synthesis Inc.


Oligonucleotides Synthesis Market report provides complete background analysis of the Healthcare IT industry which includes an assessment of the parental market. By thinking from customer point of view, a team of researchers, analysts and industry experts work carefully to generate this Oligonucleotides Synthesis Market research report. A high quality global market research is brought together for the success of your business at international level. Competitor analysis is one of the most important aspects of market research report which helps businesses decide upon the strategies by comparing them with the competitors. Besides, this Oligonucleotides Synthesis Market research report makes clients aware about the various strategies that are used by key players of the market.

Global oligonucleotides synthesis market is projected to register a substantial CAGR of 9.3% in the forecast period of 2019 to 2026.


Top Manufacturers Covered in the Report:

Some of the major players operating in this market are Agilent Technologies, Inc., Atdbio Ltd., LGC Limited, Bio-Synthesis Inc., Eurofins Genomics, Kaneka Eurogentec S.A., General Electric, Genscript, AJINOMOTO CO.,INC (Genedesign, Inc.), Danaher, Merck Kgaa, Lgc Biosearch Technologies, Nitto Denko, Thermo Fisher Scientific, Trilink Biotechnologies, Llc, Biolytic Lab Performance Inc., Polygen Gmbh, Quintara Biosciences, Bio Basic Inc., Danaher (Integrated Dna Technologies, Inc.), and Twist Bioscience among others.

Product Launch

·         In April 2019, GenScript launched single-stranded DNA service for the CRISPR based gene editing. This would help the researchers to accelerate the advancement of cell therapy, gene therapy as well as the transgenic animal models for the cancer research and treatments.

·         In September 2018, Kaneka Eurogentec S.A. had introduced Therapeutic Oligonucleotides for early clinical phases. GMP is certified by Belgium Authorities. With this there is an increased production of clinical and pre-clinical Oligonucleotides.


Segmentation: Global Oligonucleotides Synthesis Market

Global Oligonucleotides Synthesis Market By Product Type (DNA Oligonucleotides, RNA Oligonucleotides)

Type (Oligonucleotide-Based Drugs, Primers, Probes, Intermediate-Scale Synthesized Oligos, Large-Scale Synthesized Oligos, Linkers & Adaptors, Array-Based Oligos)

Consumables (Instruments, Kits & Reagents, Others)

Service Type (Custom Oligos, Predesigned Oligos, Oligo Synthesis)

Application (Research Applications, Therapeutic Applications, Diagnostic Applications, Others)

End User (Biopharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations, Hospitals, Others)

Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa) – Industry Trends and Forecast to 2026

Reasons to Purchase this Report

                    Current and future of Global Oligonucleotides Synthesis Market outlook in the developed and emerging markets
                    The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
                    Regions/Countries that are expected to witness the fastest growth rates during the forecast period
                    The latest developments, market shares, and strategies that are employed by the major market players


About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818

Related Report-



Tuesday, 22 October 2019

Chromatography Columns Market Sees Promising Growth| Thermo Fisher Scientific Inc., Merck kgaa, Agilent Technologies, Inc., COLE-PARMER INSTRUMENT COMPANY


The company profiles of all the major players and brands that are dominating the market are covered in the report with respect to their moves like product launches, joint ventures, mergers and acquisitions. The Chromatography Columns Market research report also explains in depth description, competitive scenario, product portfolio of key vendors and their business strategies with the help of SWOT analysis and porter's five force analysis. This market report offers an actionable market insight with which sustainable and profitable business strategies can be built. This global Chromatography Columns Market report has been prepared by conducting market research in a systematic manner.

Global chromatography columns market is projected to register a substantial CAGR of 6.1% in the forecast period 2019 to 2026.


Top Manufacturers Profiles Operating in the Chromatography Columns Market:    
  
Some of the major players operating in global chromatography columns market are Thermo Fisher Scientific Inc., Merck kgaa, Agilent Technologies, Inc., COLE-PARMER INSTRUMENT COMPANY, LLC, Bio-Rad Laboratories, Inc., Biotage, Daicel Corporation., W. R. Grace & Co.-Conn., KNAUER Wissenschaftliche Geräte GmbH, Purolite, GENERAL ELECTRIC, Danaher, Shimadzu Corporation, Nouryon, Sunresin New Materials Co Ltd Xi`, YMC Europe GmbH, WATERS, TOSOH, PerkinElmer Inc. and others.

Segmentation: Global Chromatography Columns Market

·         On the basis of column type, the market is segmented into normal phase chromatography columns, pre-packed chromatography columns and automated chromatography columns

·         On the basis of type, the market is segmented into interventional ion exchange chromatography, affinity chromatography, multimodal chromatography, gel filtration and others.

·         On the basis of capacity, the market is segmented into 1-100 ml, 100-1000 ml, more than 1l

·         On the basis of application, the market is segmented into sample preparation, resin screening, protein purification, anion and cation exchange and desalting

·         On the basis of industry, the market is segmented into nutraceuticals, academics, food & beverages, pharmaceuticals, environmental biotechnology, cosmetics and others

·         On the basis of end-user, the market is segmented into research institutes, analytical laboratories


Recent Developments

·         In March 2019, KNAUER Wissenschaftliche Geräte GmbH has launched new liquid chromatography columns and media for protein purification applicable to affinity (AC) size-exclusion (SEC), and ion-exchange (IEX) chromatography. The product launch will help company to full fill demand for protein purification and to increase company’s revenue.

·         In February 2019, Tosoh Bioscience launched TSKgel FcR-IIIA-NPR Columns first FcRγ affinity chromatography analysis column for antibody drugs, now available for sales, and will expand the market growth of the company

·         In October 2018, Biotage launched flash purification system and the Biotage Sfär family of flash purification columns. The new product range will help company to increase its revenue as company will be able full fill increasing demand for biomolecules purification

Attaining complete info about the trends and opportunities in the industry is fairly time consuming process but the market report eases it for businesses. Chromatography Columns Market research report acts as a valued source of information with which businesses can achieve a telescopic view of the current market trends, consumer’s demands and preferences, market situations, opportunities and market status. The report comprises of a number of market dynamics and estimations of the growth rate and the market value based on market dynamics and growth inducing factors. To formulate this Chromatography Columns Market report, detailed market analysis has been performed with the inputs from industry experts.

Key insights in the report:

·         Complete and distinct analysis of the market drivers and restraints
·         Key Market players involved in this industry
·         Detailed analysis of the Market Segmentation
·         Competitive analysis of the key players involved

About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818

Related Report-



Tuesday, 15 October 2019

Pharmaceutical Analytical Testing Outsourcing Market Set to Grow at Healthy CAGR forecast by 2026 with Top Key players like Pharmaceutical Product Development, LLC; Exova; Charles River; Boston Analytical


Pharmaceutical analytical testing outsourcing is the constitution of services from the manufacturing, testing and validating the pharmaceuticals and therapeutics. This involves validating pharmaceutical ingredient, compounds, manufacturing methods required for the development of these drugs. Global pharmaceutical analytical testing outsourcing market is expected to rise to an estimated value of USD 10.42 billion by 2026, registering a substantial CAGR in the forecast period of 2019-2026. Key players profiled in this report are: SGS SA; TOXIKON; Eurofins Scientific; Pace Analytical Services, LLC; Intertek Group plc; Pharmaceutical Product Development, LLC; Exova; Charles River; Boston Analytical; West Pharmaceutical Services, Inc.; Dalton Pharma Services; Merck KGaA; Cambrex Corporation; WuXi AppTec; Source BioScience; Ajinomoto Bio-Pharma; Catalent, Inc; Gateway Analytical


Segmentation: Global Pharmaceutical Analytical Testing Outsourcing Market

·         Global Pharmaceutical Analytical Testing Outsourcing Market By Service Type (Bioanalytical Testing, Method Development & Validation, Stability Testing, Others)

·         Product Type (Raw Materials, Finished Product, Active Pharmaceutical Ingredients),

·         End-Users (Pharmaceutical & Biopharmaceutical Companies, Biotechnology Industry)

·         Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026


Competitive Analysis: Global Pharmaceutical Analytical Testing Outsourcing Market
Global pharmaceutical analytical testing outsourcing market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of pharmaceutical analytical testing outsourcing market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.


Market Drivers

·         Increasing usage of pharmaceuticals and therapeutics requiring specialized manufacturing capabilities; this factor is expected to drive the growth of the market

·         Growth in modernization and innovations requiring reduction of operating costs of manufacturing and development; this factor is expected to enhance the growth of the market

·         Presence of strict regulations and requirement of pertaining to the standards provided by the authorities; this factor is expected to flourish the growth of the market

Market Restraints

·         Reliance on performance of unstable outsourced manufacturing organizations; this factor is expected to hamper the market growth

·         Concerns regarding privacy/theft of confidential data of manufacturing pharmaceuticals; this factor is expected to restrain the market growth

Reasons to Purchase this Report

·         Current and future of global pharmaceutical analytical testing outsourcing market outlook in the developed and emerging markets

·         The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period

·         Regions/Countries that are expected to witness the fastest growth rates during the forecast period
·         The latest developments, market shares, and strategies that are employed by the major market players


About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818

Related Reports:



Thursday, 10 October 2019

Medical Equipment Cooling Market: Moving Towards Brighter Future| General Air Products, Advanced Cooling Technologies, Inc., Aspen Systems Inc., Filtrine Manufacturing Company


Medical equipment requires internal cooling to ensure their smooth and efficient functioning. Proper cooling of equipments is required to ensure precise readings and results. Various equipments including X-Rays, MRI’s require combination of cooling, refrigeration and humidification to ensure its accurate and reliable readings with liquid-based or air-based methods. Global medical equipment cooling market is expected to rise from to an estimated value of USD 249.02 million by 2026 registering a steady CAGR in the forecast period of 2019-2026. Key players profiled in this report are: GLEN DIMPLEX GROUP., Legacy Chiller Systems, Inc., American Chillers, General Air Products, Advanced Cooling Technologies, Inc., Aspen Systems Inc., Filtrine Manufacturing Company, Laird Thermal Systems, Air Products and Chemicals, Inc., Drake Refrigeration Inc., Pelonis Technologies, inc., Peter Huber Kältemaschinenbau AG, TITAN Technology Limited, METRUM CRYOFLEX Sp. z o.o., Sp. k., Lytron, Motivair Corporation


Market Drivers

·         Increasing ageing population would foster the growth of this market, as old people are more prone to diseases such as diabetes, CAD etc

·         Rising number of diagnostic centers and hospitals globally would foster the growth of this market

·         Financial advantage received by medical equipment cooling would drive the growth of this market

·         Rising demand of medical imaging system and minimally invasive treatments boosts the growth

Market Restraints

·         Risk of corrosion of cooling system hinders the growth of this market

·         Presence of strict regulations and compliances regarding the approval of these equipments is expected to restrain the growth of the market

Key Developments in the Market:

·         In May, 2019 Atlas Copco announced that they had agreed to acquire Eurochiller S.r.l. With this acquisition, Atlas Copco would be expanding their product portfolio to include cooling equipments. Thus, with Atlas Corpo’s efficiency and quality in production it would bring about new and innovative cooling equipments, enhancing the growth of the cooling equipment market.

·         In November 2017, Laird Thermal Systems extended its product line of thermoelectric assembly (TEA) products with the introduction of a new, innovative and technologically advanced range of products for critical medical equipments. It has enhanced its product features and the cooling capacities to cater to medical equipment needs.

·         In May 2016, KKT chillers expanded its service capabilities by opening a new service center in Shanghai, China. This expansion was done in order to cater to the rising demand for chiller and equipment coolers by the various end-use industries.


Primary Respondents

·         Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

·         Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Competitive Analysis:

Global medical equipment cooling market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of medical equipment cooling market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Customization of the Report:

·         All segmentation provided above in this report is represented at country level

·         All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)


About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818

Related Report-


Friday, 4 October 2019

Pharmaceutical Analytical Testing Outsourcing Market Sees Promising Growth| SGS SA; TOXIKON; Eurofins Scientific; Pace Analytical Services, LLC; Intertek Group plc


Pharmaceutical analytical testing outsourcing is the constitution of services from the manufacturing, testing and validating the pharmaceuticals and therapeutics. This involves validating pharmaceutical ingredient, compounds, manufacturing methods required for the development of these drugs. Global pharmaceutical analytical testing outsourcing market is expected to rise to an estimated value of USD 10.42 billion by 2026, registering a substantial CAGR in the forecast period of 2019-2026. Key players profiled in this report are: SGS SA; TOXIKON; Eurofins Scientific; Pace Analytical Services, LLC; Intertek Group plc; Pharmaceutical Product Development, LLC; Exova; Charles River; Boston Analytical; West Pharmaceutical Services, Inc.; Dalton Pharma Services; Merck KGaA; Cambrex Corporation; WuXi AppTec; Source BioScience; Ajinomoto Bio-Pharma; Catalent, Inc; Gateway Analytical

Download PDF Sample report @

Market Drivers

·         Increasing usage of pharmaceuticals and therapeutics requiring specialized manufacturing capabilities; this factor is expected to drive the growth of the market

·         Growth in modernization and innovations requiring reduction of operating costs of manufacturing and development; this factor is expected to enhance the growth of the market

·         Presence of strict regulations and requirement of pertaining to the standards provided by the authorities; this factor is expected to flourish the growth of the market

Market Restraints

·         Reliance on performance of unstable outsourced manufacturing organizations; this factor is expected to hamper the market growth

·         Concerns regarding privacy/theft of confidential data of manufacturing pharmaceuticals; this factor is expected to restrain the market growth

Competitive Analysis: Global Pharmaceutical Analytical Testing Outsourcing Market
Global pharmaceutical analytical testing outsourcing market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of pharmaceutical analytical testing outsourcing market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.


Segmentation: Global Pharmaceutical Analytical Testing Outsourcing Market

·         Global Pharmaceutical Analytical Testing Outsourcing Market By Service Type (Bioanalytical Testing, Method Development & Validation, Stability Testing, Others)

·         Product Type (Raw Materials, Finished Product, Active Pharmaceutical Ingredients),

·         End-Users (Pharmaceutical & Biopharmaceutical Companies, Biotechnology Industry)

·         Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

Reasons to Purchase this Report

·         Current and future of global pharmaceutical analytical testing outsourcing market outlook in the developed and emerging markets

·         The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period

·         Regions/Countries that are expected to witness the fastest growth rates during the forecast period
·         The latest developments, market shares, and strategies that are employed by the major market players


About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818

Related Reports:



Thursday, 3 October 2019

Women’s Health Market showing Footprints for Strong Annual Sales| Eli Lilly and Company; Novartis AG; Pfizer Inc.


Women’s health includes all of the therapeutics, drugs, surgical offerings precautionary measures for the various disorders associated with the women population. These disorders vary from nutrition, oncology, reproductive, menopause, urological as well as other healthcare applications. Women’s health is focused on providing better management of diseases and improving the overall health of women population. Key players profiled in this report are: Eli Lilly and Company; Novartis AG; Pfizer Inc.; Merck & Co., Inc.; Novo Nordisk A/S; Amgen Inc.; Lupin Pharmaceuticals, Inc.; AstraZeneca; F. Hoffmann-La Roche Ltd; Sanofi; Johnson & Johnson Services, Inc.; GlaxoSmithKline plc; Bayer AG; Theramex; Agile Therapeutics; Blairex Laboratories, Inc.; Bristol-Myers Squibb Company; Ferring B.V.; Abbott; Enteris BioPharma; Evestra, Inc.; Gedeon Richter; HRA Pharma; JDS Therapeutics, LLC; Neurocrine Biosciences, Inc.; Noven Pharmaceuticals, Inc.; Radius Health

Global women’s health market is expected to register a steady CAGR of 4.96% in the forecast period of 2019-2026. The report contains data from the base year of 2018 and the historic year of 2017. This rise in market value can be attributed to the increased concerns by the governments of various regions to promote better healthcare services for women amid increasing prevalence of women-centric diseases like breast cancer, menopause and others.


Market Drivers

·         Increasing prevalence of preventing women related health disorders by the population and authorities is expected to promote the market value

·         Rise in the levels of research & development initiatives undertaken by various manufacturers in providing better healthcare services for women is expected to positively affect the growth of the market

·         Lack of qualitative healthcare services for women from the under-developed regions of the world is expected to provide better areas for growth of the market value

·         Changes in the lifestyle of individuals coupled with bad nutritional intake are factors driving the growth of the market


Market Restraints
·         Expiration of certain patents of pharmaceuticals is expected to hamper the growth of the market
·         Large financial costs associated with the clinical services is expected to act as a restraint to the growth of the market

·         Certain side-effects associated with the usage of these drugs is also expected to restrain the growth of the market

Customization of the Report:

·         All segmentation provided above in this report is represented at country level

·         All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)


Segmentation: Global Women’s Health Market

Global Women’s Health Market By Product Type (Devices, Drugs, Pharmaceutical Pipeline)
Treatment Type (Hormonal Treatment, Non-Hormonal Treatment, Surgeries)

Diagnosis (Bone Densitometry, Diagnostic Imaging Tests, Biopsies, Ovulation Testing, Others)
Disease Indication (Cancer, Reproductive Health, Hypothyroidism, Post-Menopausal Syndrome, Urological Disorders, Others)

End-Users (Hospitals & Clinics, Gynecology Centers, Research Institutes, Others)
Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

Reasons to Purchase this Report

·         Current and future of global women’s health market outlook in the developed and emerging markets
·         The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period

·         Regions/Countries that are expected to witness the fastest growth rates during the forecast period
·         The latest developments, market shares, and strategies that are employed by the major market players


About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818